InChI=1S/C27H36O5S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-25(24(28)15-14-17-26(29)30)33-23-20-18-22(19-21-23)27(31)32/h6-7,9-13,16,18-21,24-25,28H,2-5,8,14-15,17H2,1H3,(H,29,30)(H,31,32)/b7-6-,10-9-,12-11+,16-13+/t24-,25+/m0/s1 |
PKJINWOACFYDQN-RBVMPENBSA-N |
CCCCC\C=C/C\C=C/C=C/C=C/[C@@H](SC1=CC=C(C=C1)C(O)=O)[C@@H](O)CCCC(O)=O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
leukotriene antagonist
A drug designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.
|
|
leukotriene antagonist
A drug designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.
|
|
View more via ChEBI Ontology
4-{[(4S,5R,6E,8E,10Z,13Z)-1-carboxy-4-hydroxynonadeca-6,8,10,13-tetraen-5-yl]sulfanyl}benzoic acid
|
6(R)-(4-carboxyphenylthio)-5(S)-hydroxy-7(E),9(E),11(E),14(Z)-eicosatetraenoic acid
|
ChEBI
|
BAY u9773
|
ChemIDplus
|
BAY-u 9773
|
ChemIDplus
|
BAY-u9773
|
ChemIDplus
|
154978-38-8
|
CAS Registry Number
|
ChemIDplus
|
12466244
|
PubMed citation
|
Europe PMC
|
12598425
|
PubMed citation
|
Europe PMC
|
1659283
|
PubMed citation
|
Europe PMC
|
18315950
|
PubMed citation
|
Europe PMC
|
18503712
|
PubMed citation
|
Europe PMC
|
19118273
|
PubMed citation
|
Europe PMC
|
19563734
|
PubMed citation
|
Europe PMC
|
19941848
|
PubMed citation
|
Europe PMC
|
20014485
|
PubMed citation
|
Europe PMC
|
20423349
|
PubMed citation
|
SUBMITTER
|
21396378
|
PubMed citation
|
Europe PMC
|
21646802
|
PubMed citation
|
Europe PMC
|
21903747
|
PubMed citation
|
SUBMITTER
|
23801612
|
PubMed citation
|
Europe PMC
|
25408836
|
PubMed citation
|
Europe PMC
|
25707327
|
PubMed citation
|
Europe PMC
|
27198524
|
PubMed citation
|
Europe PMC
|
7698171
|
PubMed citation
|
SUBMITTER
|
8982726
|
PubMed citation
|
Europe PMC
|
9597121
|
PubMed citation
|
Europe PMC
|
9797038
|
PubMed citation
|
Europe PMC
|
|